Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz
M
M
University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Kantarjian
H
H
Kurzrock
R
R
Gutterman
J U
JU
D004341:Drug Evaluation; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000008:administration & dosage / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma